Aarti Drugs hits 52-week high on share buyback plan

The stock surged 7% to Rs 689, also its 52-week high on NSE in early morning trade after the company said that its board will meet on January 8, to consider share buyback proposal

shares, buyback, invest, mutual fund, income, dividend

Premium

SI Reporter Mumbai

Last Updated : Jan 03 2018 | 9:37 AM IST

Aarti Drugs surged 7% to Rs 689, also its 52-week high on the National Stock Exchange (NSE) in early morning trade after the company said that its board will meet on January 8, to consider share buyback proposal.

“A meeting of board of directors of the Company is scheduled to be held on Monday, 8th January, 2018, to consider inter alia, proposal of buyback of the fully paid-up equity shares of the Company including matters related/incidental thereto,” Aarti Drugs said in a regulatory filing.

As of September 2017, the promoters held 62.49% stake in pharmaceutical company. Individual shareholders

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in